ERBB2 and neoplasm: Based on the logistic regression, we screened for predictors and constructed a concise and well fitted nomogram containing the variables of tumor size, hormone receptor status, regimens of neoadjuvant chemotherapy and cycles of neoadjuvant chemotherapy to predict the pCR rate of HER2 negative patients.